Eurofins Expands Its Network of COVID-19 Testing Centers, Including Airports, Ports, Train Stations and Drive-Through Testing Centers, to Enable Convenient and Safe International Travel
12 Août 2021 - 7:46AM
Business Wire
As international travel for leisure and business continues to
gather momentum, easy access to reliable and cost-effective testing
is paramount to ensure safe and hassle-free travel experiences.
Alongside further vaccination levels, wide-spread testing for
SARS-CoV-2 (COVID-19), and sequencing of positive samples, remains
crucial to keep the pandemic under control and potentially avoid
breeding grounds for further variants. Eurofins (Paris:ERF) remains
fully committed to providing holistic testing services for
SARS-CoV-2 (COVID-19), not only through home-testing solutions, but
also through an extensive, ever-increasing network of testing
centers in travel hubs.
To support millions of passengers in the coming months, Eurofins
has rapidly expanded its network of strategically located testing
centers to about 1000 across Europe, adding around 500 centers to
the network within the last 6 weeks. These sampling stations, in
about 20 countries across Europe, cover most major business and
tourist hubs. Eurofins intends to keep growing this network and
provide unparalleled testing coverage to facilitate European and
global travel.
Airports play a major role as travel gateways, and Eurofins has
established test centers in 40 airports in Europe. Over 30 testing
centers in and near major train stations, such as Brussels-south
and Paris Roissy airport train stations, and seaports for cruise
ship testing, such as Southampton, Athens and Barcelona complement
Eurofins’ existing network of testing centers at travel hubs.
Additionally, Eurofins offers drive-through testing centers on
several major highways and airport access roads, recently opening
drive-through testing centers in the UK and Germany, as well as the
deployment of an increasing number of mobile sampling buses across
Europe.
Eurofins continues to invest in laboratory capacity and IT
solutions to ensure fast turn-around times for test results (as low
as 6 hours, in some cases, after receiving the sample at the
laboratory for gold standard PCR tests). Eurofins operates an
intuitive web portal in 19 languages, to book testing appointments
and access testing information.
For more information visit
https://www.covid19testing.eu/.
Notes to editor:
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With 55,000 staff across a network
of 900 laboratories in over 50 countries, Eurofins’ companies offer
a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210811005953/en/
Livia Baratta Investor Relations Eurofins Scientific SE
ir@eurofins.com
Eurofins Scientific (EU:ERF)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Eurofins Scientific (EU:ERF)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024